Roche Holding stock heads into the open after a 1.0% drop
Published on 09/21/2026 at 08:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Roche Holding stock closed at CHF 364.80 on the SIX Swiss Exchange on September 18, 2026, marking a 1.0% decline from the previous session. In the same session, the Swiss Market Index ended higher, so Roche lagged the broader Swiss market despite intraday trading in a range between roughly CHF 364 and CHF 365.
September 18, 2026 in numbers
Roche Holding AG (ISIN CH0012032048) finished the last completed session on September 18, 2026 at CHF 364.80 on SIX Swiss Exchange, after opening near CHF 364.60 and fluctuating within the intraday range around CHF 364.80 per data from a quote overview. The move represented a loss of about 1.03% on the day, following a prior close near CHF 368.60 earlier in the week, and left the shares below the recent level of CHF 356.80 cited as the year-to-date reference in a recent interview that highlighted an approximately 9% gain since the start of the year.MSN The stock thus traded slightly above its early year level while still well within its 52-week range, with turnover on September 18, 2026 exceeding 140,000 shares according to the detailed order book data from the Swiss market quote page.
A key driver for the weaker session was news coverage that Roche shares were lower as the company opened a new US research center and received a positive recommendation from European regulators for expanding the use of its multiple sclerosis drug Ocrevus in children.finanzen.ch That report tied the session decline directly to the market reaction around the new US facility and the pediatric Ocrevus recommendation, even as the broader Swiss equity benchmark showed gains in the same period.
Today’s drivers around research and approvals
Today, September 21, 2026, investor attention around Roche focuses on ongoing developments from its US research expansion and regulatory momentum for Ocrevus following the recent EU recommendation, themes that continue to shape sentiment after the prior session’s move.finanzen.ch No major company-specific events such as an earnings release, annual general meeting or ex-dividend date are scheduled for today in the publicly accessible investor information, so trading into the open is likely to be shaped mainly by further interpretation of the recent research and regulatory news alongside the broader performance of the Swiss Market Index and international healthcare peers.
